North Shore-LIJ Health System's Feinstein Institute to Receive $250,000 Grant from Lymphoma Research Foundation Grant to support research of Chronic Lymphocytic Leukemia

The Feinstein Institute for Medical Research announced today it will receive a $250,000 grant aimed at gaining a better understanding of chronic lymphocytic leukemia (CLL) and other blood cancers.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

MANHASSET, NY (PRWEB) July 25, 2013

The Feinstein Institute for Medical Research announced today it will receive a $250,000 grant aimed at gaining a better understanding of chronic lymphocytic leukemia (CLL) and other blood cancers.

The two-year grant from the Lymphoma Research Foundation (LRF), the nation’s largest non-profit organization devoted to funding innovative lymphoma research, was awarded to
Nicholas Chiorazzi, MD, head of the Karches Center for Chronic Lymphocytic Leukemia Research at the Feinstein Institute. Dr. Chiorazzi’s lab and that of his collaborator, Dr. Matthew D. Scharff at the Albert Einstein College of Medicine in the Bronx, will utilize the funds to research gene expression and DNA methylation signatures linked to in vivo CLL/small lymphocytic lymphoma B-cell kinetics and outcome.

“I am grateful to the Lymphoma Research Foundation for supporting this research so that Dr. Scharff and I can work to better understand CLL and ultimately find a new, improved treatment for the devastating disease,” said Dr. Chiorazzi.

The grant received from LRF is a portion of a $2.15 million grant divided among seven scientists investigating the biology of or new therapies for lymphoma.

“As evident in our recent funding of more than $2 million in research, the Lymphoma Research Foundation is dedicated to finding a cure for lymphoma through an aggressively funded research program,” said Diane Blum, LRF chief executive officer. “We remain grateful to our supporters whose generosity enables the Foundation to work toward its mission of eradicating lymphoma through innovative research.”

Recommendations for research funding were made by the LRF Scientific Advisory Board, which is comprised of the world’s leading lymphoma researchers and oncologists. The award recommendations were then approved by the LRF Board of Directors.
Grantees include:

About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded more than $54 million in lymphoma-specific research. For additional information on LRF’s research, education and services, please visit lymphoma.org.

About The Feinstein Institute for Medical Research
Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 5th percentile of all National Institutes of Health grants awarded to research centers. For more information, visit http://www.FeinsteinInstitute.org.


Contact

  • Emily Ng
    North Shore-LIJ Health System
    516-562-2670
    Email